Skip to content

Histamine H1 receptor occupancy of amino group-containing non-sedating antihistamines measured by PET in healthy male volunteers

Histamine H1 receptor occupancy of amino group-containing non-sedating antihistamines measured by PET in healthy male volunteers - Histamine H1 receptor occupancy of non-sedating antihistamines

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029704
Enrollment
8
Registered
2017-11-07
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy male volunteers

Interventions

Positron emission tomography (PET) imaging with [11C]doxepin, a PET tracer that specifically binds to H1Rs, in healthy male volunteers after a single oral administration of placebo in a double-blind c

Sponsors

Department of Pharmacology, Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Healthy normal male subjects examined by health check using blood and brain MRI examination before PET scan

Exclusion criteria

Exclusion criteria: Healthy normal male subjects taking any drugs Healthy normal male subjects who became another volunteers of PET studies. Healthy normal male subjects with severe allergic diseases Healthy normal male subjects with family history of glaucoma and benign prostatic hypertrophy Healthy normal male subjects who can not take antihistamines and anticholinergic drugs.

Design outcomes

Primary

MeasureTime frame
Histamine H1 receptor occupancy of desloratadine 5 mg and loratadine 10 mg at Tmax after single oral administration

Secondary

MeasureTime frame
Correlation between histamine H1 receptor occupancy and subjective sleepiness and plasma pharmakokinetics after single oral administration of desloratadine 5 mg and loratadine 10 mg.

Countries

Japan

Contacts

Public ContactManabu Tashiro

Tohoku University, Cyclotron and Radioisotope Center Division of Cyclotron Nuclear Medicine

mtashiro@m.tohoku.ac.jp022-795-7802

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026